These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 33324420)

  • 1. Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?
    Sadeqi Nezhad M; Seifalian A; Bagheri N; Yaghoubi S; Karimi MH; Adbollahpour-Alitappeh M
    Front Immunol; 2020; 11():603237. PubMed ID: 33324420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity as a target for chimeric immune receptor therapy: A new vision to therapeutic potential.
    Haddadi MH; Hajizadeh-Saffar E; Khosravi-Maharlooei M; Basiri M; Negahdari B; Baharvand H
    Blood Rev; 2020 May; 41():100645. PubMed ID: 31813654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
    Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
    Front Immunol; 2018; 9():2359. PubMed ID: 30369931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAR Treg: A new approach in the treatment of autoimmune diseases.
    Beheshti SA; Shamsasenjan K; Ahmadi M; Abbasi B
    Int Immunopharmacol; 2022 Jan; 102():108409. PubMed ID: 34863655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing autoimmune Rheumatic disease treatment: CAR-T Cell Therapies - Evidence, Safety, and future directions.
    Ohno R; Nakamura A
    Semin Arthritis Rheum; 2024 Aug; 67():152479. PubMed ID: 38810569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAR T cells for treating autoimmune diseases.
    Blache U; Tretbar S; Koehl U; Mougiakakos D; Fricke S
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37996128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CARs: a new approach for the treatment of autoimmune diseases.
    Sun Y; Yuan Y; Zhang B; Zhang X
    Sci China Life Sci; 2023 Apr; 66(4):711-728. PubMed ID: 36346550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The making and function of CAR cells.
    Zabel M; Tauber PA; Pickl WF
    Immunol Lett; 2019 Aug; 212():53-69. PubMed ID: 31181279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
    Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F
    J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing the inherent power of chimeric antigen receptor (CAR)-expressing regulatory T cells (CAR-Tregs) to treat autoimmune-related disorders.
    Kahmini FR; Shahgaldi S
    Mol Biol Rep; 2022 May; 49(5):4069-4078. PubMed ID: 35534581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8
    Whittington KB; Prislovsky A; Beaty J; Albritton L; Radic M; Rosloniec EF
    J Immunol; 2022 Jan; 208(1):16-26. PubMed ID: 34819392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma.
    Sommer C; Boldajipour B; Kuo TC; Bentley T; Sutton J; Chen A; Geng T; Dong H; Galetto R; Valton J; Pertel T; Juillerat A; Gariboldi A; Pascua E; Brown C; Chin SM; Sai T; Ni Y; Duchateau P; Smith J; Rajpal A; Van Blarcom T; Chaparro-Riggers J; Sasu BJ
    Mol Ther; 2019 Jun; 27(6):1126-1138. PubMed ID: 31005597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of CAR-T cell technology in autoimmune diseases and human immunodeficiency virus infection treatment.
    Adabi N; Pordel S; Rezaee MA; Shobeiri FS; Shobeiri SS
    J Gene Med; 2023 May; 25(5):e3484. PubMed ID: 36781390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy With Regulatory T Cells: A Beneficial Alliance.
    Biswas M; Kumar SRP; Terhorst C; Herzog RW
    Front Immunol; 2018; 9():554. PubMed ID: 29616042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric antigen receptor-engineered regulatory T lymphocytes: promise for immunotherapy of autoimmune disease.
    Yi L; Weifan Y; Huan Y
    Cytotherapy; 2019 Sep; 21(9):925-934. PubMed ID: 31105041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD.
    Imura Y; Ando M; Kondo T; Ito M; Yoshimura A
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32525846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric antigen receptor-engineered T-cell therapy for liver cancer.
    Chen Y; E CY; Gong ZW; Liu S; Wang ZX; Yang YS; Zhang XW
    Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):301-309. PubMed ID: 29861325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.
    Koristka S; Kegler A; Bergmann R; Arndt C; Feldmann A; Albert S; Cartellieri M; Ehninger A; Ehninger G; Middeke JM; Bornhäuser M; Schmitz M; Pietzsch J; Akgün K; Ziemssen T; Steinbach J; Bachmann MP
    J Autoimmun; 2018 Jun; 90():116-131. PubMed ID: 29503042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
    Janssens I; Cools N
    Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
    Terry LV; Oo YH
    Front Immunol; 2020; 11():565518. PubMed ID: 33072105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.